论文部分内容阅读
本文介绍了我国心脏支架供应链运作的现状,比较了代理和直销两种销售方式,从供应链运营的角度分析了代理制销售模式下心脏支架流通环节可能出现的安全隐患,指出了监管的漏洞和控制的盲区,接着从法律法规、行业标准、成本分担结构以及机制建设等角度进一步深入探讨了隐患的成因,最后提出了应对建议,包括提高从业资质认证标准、规范运作流程、完善信息监控及问责机制等方面。
This article introduces the status quo of the operation of the supply chain of heart stent in our country, compares the two sales methods of agency and direct sales, analyzes the possible hidden dangers of the circulation of the cardiac stent under the agent sales model from the perspective of supply chain operation, points out the regulatory loopholes And control of the blind spot, and then from the perspectives of laws and regulations, industry standards, cost-sharing structure and mechanism construction to further explore the causes of the hidden dangers, and finally put forward countermeasures and suggestions, including improving the qualification standards for practitioners, standardize operational processes, improve information monitoring and Accountability mechanisms.